tiprankstipranks
Trending News
More News >
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market
Advertisement

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Revenue

Compare
0 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Revenue

Shanghai Haohai Biological Technology Co., Ltd. Class H had a revenue of 685.86M in the quarter ending Jun 30, 2025, with 10.88%. This bring the company's revenue in the last twelve months to 2.60B, Increased -2.72%. In the fiscal year ending Dec 31, 2024, Shanghai Haohai Biological Technology Co., Ltd. Class H had annual revenue of 2.68B with 1.70% growth.
Revenue (ttm)
2.60B
Revenue Growth
-5.62%
P/S Ratio
4.50
Revenue/Employee
HK$1,242,888
Employees
2,156
Market Cap
HK$12.05B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
2.68B44.76M+101.70%
Dec 31, 2023
2.63B531.47M+125.27%
Dec 31, 2022
2.10B353.32M+120.19%
Dec 31, 2021
1.75B425.69M+132.14%
Dec 31, 2020
1.32B-271.07M+83.01%
Dec 31, 2019
1.60B49.67M+103.21%
Dec 31, 2018
1.55B200.97M+114.94%
Dec 31, 2017
1.34B493.70M+158.00%
Dec 31, 2016
851.16M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis